Inappropriate DNA methylation of the upstream regulators of the mammalian target of rapamycin (mTOR) leads to inflammation by promoting the upregulation of DNMT1 in patients with DKD [12]. The gene discussed is DNMT1; the disease is diabetic kidney disease.